Head-To-Head Comparison: Aeon Global Health (AGHC) and Guardant Health (GH)

Aeon Global Health (OTCMKTS:AGHC) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations and dividends.

Earnings and Valuation

This table compares Aeon Global Health and Guardant Health’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Aeon Global Health $16.30 million 0.23 -$8.00 million ($1.15) -0.33
Guardant Health $90.64 million 86.31 -$85.06 million ($2.80) -32.58

Aeon Global Health has higher earnings, but lower revenue than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Aeon Global Health, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Aeon Global Health and Guardant Health, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aeon Global Health 0 1 0 0 2.00
Guardant Health 0 1 4 0 2.80

Guardant Health has a consensus target price of $72.50, suggesting a potential downside of 20.53%. Given Guardant Health’s stronger consensus rating and higher probable upside, analysts plainly believe Guardant Health is more favorable than Aeon Global Health.

Profitability

This table compares Aeon Global Health and Guardant Health’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Aeon Global Health -29.16% -290.44% -38.31%
Guardant Health N/A N/A N/A

Institutional and Insider Ownership

69.5% of Guardant Health shares are held by institutional investors. 11.5% of Aeon Global Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Guardant Health beats Aeon Global Health on 9 of the 13 factors compared between the two stocks.

About Aeon Global Health

Aeon Global Health Corp., together with its subsidiaries, provides various clinical laboratory testing services in the United States. The company operates through Laboratory Testing Services and Web-Based Software segments. Its laboratory testing services include the testing of an individual's blood, urine, or saliva for the presence of drugs or chemicals, as well as the patient's DNA profile. The company primarily offers medical toxicology, DNA pharmacogenomics, cancer genetic testing, and molecular biology tests. It also provides Web-based services as software as a service for Web-based revenue cycle management applications; and telehealth products and services that enable healthcare organizations to coordinate care for patients, and enhance related administrative and clinical workflows, as well as compliance with regulatory requirements. In addition, AEON Global Health Corp. offers post contract customer support services. The company was formerly known as Authentidate Holding Corp. and changed its name to Aeon Global Health Corp. in January 2018. Aeon Global Health Corp. is headquartered in Gainesville, Georgia.

About Guardant Health

Guardant Health, Inc., a precision oncology company, provides non-invasive cancer diagnostics. It offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes from circulating tumor DNA (ctDNA); and GuardantOMNI, a broader panel measuring various genes from ctDNA. The company also provides LUNAR-1 for recurrence detection in cancer survivors; and LUNAR-2 for early detection of cancer in higher risk individuals. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California.

Receive News & Ratings for Aeon Global Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeon Global Health and related companies with MarketBeat.com's FREE daily email newsletter.